Five Americans came home from facelifts in Mexico with infections that surfaced a month later

At least five U.S. residents developed nontuberculous mycobacterial infections after facelift surgery at a single hospital in Zapopan, Jalisco, Mexico, the Centers for Disease Control and Prevention reported on October 22. The patients, from California (two), Illinois, Texas and Florida, got sick a median of 33 days after their operations, long after they were back home.

Tech news worth reading: Get Techpresso, the daily email with the most interesting tech news and insights, read by 400,000+ professionals from Google, Apple and OpenAI.

Get Techpresso →

We may earn a commission if you sign up.

That delay is the core of the problem. Nothing about a freshly closed incision announces what is growing underneath it.

Five patients, four states and one surgeon

The report, a “Notes from the Field” item in the CDC’s Morbidity and Mortality Weekly Report, was written by Neel Swamy and 21 co-authors from the CDC, the County of San Diego Health and Human Services Agency and Mexico’s Ministry of Health. All five patients had their procedures with the same surgeon at the same facility. The report does not name either, and does not give ages.

The operations took place between April and September 2025: patient D in April, patients B and C in July, and patients A and E in September. All were facelifts, and all five patients sought treatment in the United States once symptoms appeared.

The wording matters. The CDC says “at least five,” which makes five the confirmed floor rather than a ceiling. Nontuberculous mycobacteria are not nationally notifiable in the United States, so cases surface only when a treating physician, a county health department or a patient decides to report one, and the people who never reported are invisible in the count.

A month later, and sometimes much later

The median time from surgery to the first symptom was 33 days, with a range of 4 to 112 days. Patient A developed multiple seromas, pockets of fluid on the face and neck, starting eight days after surgery. The infections were slow to confirm as well: the median time from surgery to a positive culture was 76 days, ranging from 47 to 116.

The gap matters because these organisms grow slowly and ordinary wound infections are far more common, so a doctor seeing swelling and drainage a month after a facelift may not think of them first. The CDC authors tell clinicians to consider nontuberculous mycobacteria in any postsurgical infection, especially after cosmetic procedures.

The group of organisms involved are bacteria found widely in the environment, including in water, which is why the report’s authors keep returning to water and sterilization as possible routes into an operating room. They do not claim to have identified the route.

Treatment was long. It included medication, drainage procedures (patient A had four) and corrective surgery for scarring and disfigurement. Some patients were still in treatment when the report was published, and there were no deaths. The report also leaves some dates loose: its title gives April to September 2025, its case definition reaches from January 1, 2025 to July 1, 2026, and a figure caption runs from April 2025 to March 2026, so the exact reporting window is wider than the five surgery dates suggest.

Mycobacterium abscessus, and what the inspection turned up

Whole genome sequencing tied three of the patients together. Patients A, B and C carried Mycobacterium abscessus sequence type 56, with only one or two single-letter differences in their DNA, which the authors say suggests a likely common source. Patient E had a different strain of the same species, sequence type 42, and patient D grew a different species, Mycobacterium fortuitum.

The authors write that these differences do not rule out a shared source at the hospital or in its environment, such as a water supply. An inspection in February 2026 found lapses in surgical instrument sterilization. Authorities closed the operating area and confiscated the surgeon’s instruments. The investigation is continuing, and the CDC and Mexico’s health ministry have asked for a list of U.S. residents treated at the facility from April to September 2025.

A pattern the CDC has seen before

Earlier clusters have taken the same shape. The CDC reported nontuberculous mycobacterial infections in U.S. medical tourists after plastic surgery in the Dominican Republic in 2017, and infections after cosmetic surgery in Florida across nine states in 2022 and 2023. A health system’s clinical alert dated February 2026 already covered surgical-site infections after surgery in Mexico since July 2025.

The agency has also pointed to a wider problem. A CDC release on adverse outcomes linked to travel-related cosmetic procedures and a June 2026 Emerging Infectious Diseases analysis of adverse outcomes among U.S. residents from 2014 to 2024 frame these infections as one slice of a larger set of complications.

Because these infections are not nationally notifiable in the United States, the report encourages clinicians to submit cases to the CDC’s Medical Tourism Surveillance System. For travelers, the authors note only that accreditation and certification standards can differ outside the country. How many other U.S. patients were treated at the facility between April and September 2025 is the figure the investigation has yet to supply.

This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.

Tech news worth reading: Get Techpresso →

We may earn a commission if you sign up.